Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 76, Issue Suppl 2
SAT0171 Abp 501 biosmilar to adalimumab: final safety, immunogenicity, and efficacy results from an open-label extension study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0171 Abp 501 biosmilar to adalimumab: final safety, immunogenicity, and efficacy results from an open-label extension study
Free
Online download statistics by month:
Online download statistics by month: June 2017 to March 2024
Abstract
Full
Pdf
Jun 2017
39
0
0
Jul 2017
12
0
0
Aug 2017
12
0
1
Sep 2017
20
0
5
Oct 2017
16
0
6
Nov 2017
22
0
4
Dec 2017
14
0
3
Jan 2018
22
0
7
Feb 2018
24
0
4
Mar 2018
24
0
6
Apr 2018
28
0
1
May 2018
26
0
2
Jun 2018
14
0
1
Jul 2018
14
0
1
Aug 2018
22
0
9
Sep 2018
8
0
4
Oct 2018
18
0
10
Nov 2018
45
0
14
Dec 2018
24
0
13
Jan 2019
16
0
14
Feb 2019
43
0
5
Mar 2019
22
0
12
Apr 2019
22
0
6
May 2019
6
0
5
Jun 2019
18
0
2
Jul 2019
21
0
11
Aug 2019
28
0
5
Sep 2019
4
0
2
Oct 2019
8
0
3
Nov 2019
8
0
2
Dec 2019
2
0
1
Jan 2020
4
0
6
Feb 2020
2
0
2
Mar 2020
0
0
1
Apr 2020
8
0
5
May 2020
2
0
4
Jun 2020
12
0
8
Jul 2020
10
0
1
Aug 2020
12
0
5
Sep 2020
11
0
3
Oct 2020
10
0
4
Nov 2020
12
0
2
Dec 2020
10
0
2
Feb 2021
3
0
2
Mar 2021
3
0
1
Apr 2021
3
0
4
May 2021
3
0
4
Jun 2021
0
0
2
Jul 2021
0
0
5
Aug 2021
0
0
2
Sep 2021
1
0
1
Oct 2021
2
0
16
Nov 2021
14
0
14
Dec 2021
4
0
1
Jan 2022
8
0
2
Feb 2022
9
0
7
Mar 2022
0
0
1
May 2022
14
0
7
Jun 2022
18
0
3
Jul 2022
16
0
0
Aug 2022
16
0
6
Sep 2022
6
0
7
Oct 2022
10
0
4
Nov 2022
12
0
7
Dec 2022
14
0
0
Jan 2023
8
0
2
Feb 2023
7
0
2
Mar 2023
8
0
1
Apr 2023
1
0
2
May 2023
2
0
3
Jun 2023
2
0
0
Jul 2023
4
0
3
Aug 2023
0
0
1
Oct 2023
2
0
1
Nov 2023
2
0
0
Dec 2023
12
0
0
Jan 2024
14
0
0
Feb 2024
2
0
1
Mar 2024
10
0
4
Total
925
0
318
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?